CTV quoted Blair Leavitt, a UBC neurologist, about an experimental drug that has showed promise in lowering levels of brain toxins caused by Huntington’s disease.
“We wish we could get these therapies to patients faster, but we have to be careful and ensure they are safe,” Leavitt said.
